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Abstracts
Background: The production of extended-spectrum β-lactamases (ESBLs) confer resistance to the commonly used
beta-lactam antimicrobials and ESBL–producing bacteria render treatment difficulty in human and veterinary
medicine. ESBL–producing bacteria have emerged in livestock in recent years, which may raise concerns regarding
possible transfer of such bacteria through the food chain. The swine industry is important in Taiwan, but
investigations regarding the status of ESBL in swine are limited.
Results: We collected 275 fecal swab samples from piglets with diarrhea in 16 swine farms located in central and
southern Taiwan from January to December 2015 and screened them for ESBL–producing Escherichia coli. ESBL
producers were confirmed phenotypically by combination disc test and genotypically by polymerase chain reaction
and DNA sequencing. The occurrence rate of ESBL–producing E. coli was 19.7% (54 of 275), and all were obtained
in swine farms located in southern Taiwan. blaCTX-M-1-group and blaCTX-M-9-group were the two blaCTX-M groups found.
blaCTX-M-55 (34 of 54; 63.0%) and blaCTX-M-15 (16 of 54; 29.6%), which belong to the blaCTX-M-1-group, were the two
major bla gene types, whereas blaCTX-M-65 was the only type found in the blaCTX-M-9 group. Twenty-seven strains
contained blaTEM-1, and the other 27 strains contained blaTEM-116. One strain found in Pingtung harbored three bla
genes: blaTEM-116, blaCTX-M-55, and blaCTX-M-65. ESBL–producing E. coli exhibited a multidrug-resistant phenotype, and
multilocus sequence typing revealed that the ST10 clonal complexes, including ST10, 167, 44, and 617 accounted
for 35% (19 of 54) of these strains.
Conclusions: ESBL-producing E. coli from piglets with diarrhea were isolated from swine farms located in southern
Taiwan. The most commonly detected bla were blaCTX-M-15 and blaCTX-M-55. The ST10 clonal complexes comprised
most of our ESBL-producing E. coli strains. Fecal shedding from swine may contaminate the environment, resulting
in public health concerns; thus, continued surveillance of ESBL is essential in swine and in other food animals.
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Background
Diarrhea is a common clinical syndrome in the swine
industry and may be classified into three entities.
Sucking piglets usually exhibit neonatal diarrhea a few
days after birth, and young piglet diarrhea occurs
from the first week after birth to weaning [1]. Older
piglets, commonly 2 weeks after weaning, may
contract post-weaning diarrhea. Neonatal and post-
weaning diarrhea are caused by pathogenic Escheri-
chia coli, and causative agents of young piglet
diarrhea may include transmissible gastroenteritis
virus, rotavirus, coccidia, and E. coli [1]. Occurrence
of diarrheal disease can be reduced by the vaccination
of sows to let piglets obtain maternal antibodies.
However, measures such as the use of antibiotic sup-
plements in feed are also frequently practiced along
with vaccination to reduce the incidence of diarrhea.
If prudent usage of antibiotics is not taken into con-
sideration, the massive, indiscriminate, and long-term
use of antibiotics in veterinary practice may contrib-
ute to the selection and spread of drug-resistant
bacteria [2, 3].
Production of extended-spectrum β-lactamases
(ESBLs) confers resistance to the frequently used
beta-lactam antimicrobial agents, including the third-
generation cephalosporins such as ceftriaxone, ceftazi-
dime, and ceftiofur. However, ESBLs are inhibited by
the β-lactamases inhibitors clavulanic acid, sulbactam,
and tazobactam [4]. TEM, SHV, and CTX-M-types
are the three major families of ESBL [4]. All CTX-M-
types enzymes are ESBLs, whereas the TEM- and
SHV- types of ESBL arise by point mutation at spe-
cific residues from the natural TEM-1/TEM-2 and
SHV-1 β-lactamase [5]. The production of ESBLs is
mainly plasmid mediated, and such plasmids often
carry genes that encode resistance to other classes of
antimicrobials, such as fluoroquinolones and amino-
glycosides [6]. ESBLs are widely distributed in Entero-
bacteriaceae, particularly in E. coli, and the rapid
emergence and spread of ESBL-producing E. coli have
been reported in food animals globally [7]. Such find-
ings raise concerns about the possible transfer of
ESBL producers through the food chain, thus present-
ing a hazard to public health [8].
The status of ESBL-producing E. coli in food animals in
Taiwan has only been reported in cows [9]. Although a
foot and mouth disease outbreak in 1997 had a great im-
pact on the swine industry [10], swine are still among the
most important agricultural products in Taiwan. The ob-
jective of this study is to analyze the fecal carriage of
ESBL-producing E. coli isolated from piglets with diarrhea
in 16 pig farms located in central and southern Taiwan. It
is important to screen for the ESBL producers from food
animals such as swine from a public health perspective.
Methods
Sample collection
A total of 275 fecal swab samples were collected from
the piglets with diarrhea before weaning from 16 swine
farms in Taiwan (one in Taichung, one in Nantou, one
in Chunghua, two in Yunlin, four in Chiayi, one in
Tainan, and six in Pingtung) from January to December
2015. These 16 farms belong to the same swine industry
corporation. Isolating E. coli from feces in piglets with
diarrhea and preparing “tailored vaccine” has been rou-
tinely practiced in these farms. These E. coli were cul-
tured, inactivated and used as a vaccine component to
feed pregnant sows. Neonatal piglets will presumably ob-
tain maternal antibodies when sucking colostrum. Oc-
currence of neonatal diarrhea due to E. coli infection
may be reduced as long as piglets have enough maternal
antibody. We shared these fecal swab samples and inoc-
ulated on CHROMagar ESBL (CHROMagar, Paris,
France) to screen for ESBL-producing E. coli. Any pink
colony that appeared on the agar after incubation at 37 °C
for 16–18 h was initially designated as ESBL-producing E.
coli since they were resistant to cefotaxime and/or ceftazi-
dime, and its identity as E. coli was confirmed with the
RapIDTM ONE System (RapIDTM, Lenexa, KS, USA).
Confirmed E. coli strains were stored at −80 °C for further
study.
ESBL testing
E. coli isolates were tested phenotypically for ESBL pro-
duction by combination disc tests with cefotaxime and
ceftazidime (30 μg), with and without clavulanic acid
(10 μg), as stated by the guidelines of the Clinical and
Laboratory Standards Institute [11]. The tested E. coli
strains were plated on Muller-Hinton agar at a concen-
tration of 0.5 McFarland standards and grown at 35 °C
for 16–18 h. A difference of 5 mm or more in the inhib-
ition zones for at least one cefotaxime or ceftazidime/
clavulanic acid combination versus the corresponding
cefotaxime or ceftazidime alone was used to define an
ESBL producer. Klebsiella pneumoniae ATCC 700603
and E. coli ATCC 25922 were used as the positive and
negative controls, respectively [11].
Detection of bla genes
The E. coli strains that were phenotypically confirmed to
be ESBL producers were examined with polymerase
chain reaction (PCR) to detect their bla genes. The
tested strains were cultured for 16–18 h at 37 °C on
tryptic soy agar plates (Difco/Becton Dickinson, Franklin
Lakes, NJ, USA), and a loopful of bacterial cells was re-
suspended in 200 μL ddH2O and boiled for 10 min [12].
After centrifugation at 12,000 g for 10 min, the super-
natant was saved as the source of template DNA for
PCR. The primer sequences used to amplify blaTEM,
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blaSHV, blaCTX-M-1-group, blaCTX-M-2-group, blaCTX-M-8-
group, blaCTX-M-9-group, and blaCTX-M-25-group, the anneal-
ing temperature, and the expected PCR product sizes
are specified in Table 1. The PCR cycling program was
set as follows using a LifeEco thermocycler (Bioer Tech-
nology, Hangzhou, China): initial denaturation at 95 °C
for 5 min, followed by 35 cycles at 95 °C for 30 s, then
the annealing temperature specified in Table 1 for 40 s,
and 72 °C extension for 1 min. The reaction was then
maintained at 72 °C for 10 min. Ten microliters of each
PCR sample was loaded onto a 1.2% agarose gel and
electrophoresed at 100 volts for 40 min. The gels were
then stained with a fluorescent nucleic acid dye (Bio-
tium, Hayward, CA, USA) and examined under a blue
light LED illuminator (Smobio, Hsinchu City, Taiwan).
The PCR products were then sliced from the agarose gel
and subjected to further purification and sequenced by
ABI 3130 x1 Genetic Analyzer (Applied Biosystems,
Foster, CA, USA) in Center for Genomic Medicine, Na-
tional Cheng Kung University, Tainan, Taiwan. The re-
sults were analyzed with MEGA 6.0 and examined with
the NCBI BLAST program (http://www.ncbi.nlm.nih.gov/
blast/) and β-lactamase database (http://www.ncbi.nlm.-
nih.gov/pathogens/submit-beta-lactamase).
Antimicrobial susceptibility testing
The ESBL-producing E. coli strains were tested for sus-
ceptibility to antimicrobial agents using the disc agar dif-
fusion method [11]. The antimicrobial agents tested
included amikacin 30 μg, ampicillin 10 μg, amoxyclav
30 μg, ceftiofur 30 μg, cephalothin 30 μg, ciprofloxacin
10 μg, doxycycline 30 μg, enrofloxacin 5 μg, florfenicol
30 μg, gentamicin 30 μg, nalidixic acid 30 μg, strepto-
mycin 10 μg, co-trimoxazole 25 μg, tetracycline 10 μg;
all of the discs were purchased from Oxoid (Oxoid,
Hampshire, UK).
E. coli genotyping
Our E. coli strains were analyzed genotypically by multi-
locus sequence typing. DNA fragments derived from
adk, fumC, gyrB, icd, mdh, purA, and recA were ampli-
fied by PCR, sequenced, and then uploaded to the MLST
website (http://enterobase.warwick.ac.uk/) for compari-
son [13]. Phylogenetic analysis was performed using Bio-
Numerics Software version 7.0 (Applied Maths, Sint-
Martens-Latem, Belgium).
Results
Fifty-four samples exhibited pink colonies on CHROMa-
gar ESBL, initially indicating an identity of ESBL–produ-
cing E. coli. All of these strains were then confirmed
biochemically with RapIDTM ONE System as E. coli, and
they were not hemolytic when grown on blood agar.
These 54 strains exhibited the ESBL phenotype when
assayed by combination disc tests. From our results, we
did not detect any ESBL–producing E. coli in diseased
piglets from any of the five swine farms in Taichung,
Nantou, Chunghua, and Yunlin, which were located in
central Taiwan. ESBL–producing E. coli were all ob-
tained in swine farms in southern Taiwan, including
Chiayi, Tainan, and Pingtung, with the exception of one
farm in Chiayi (farm ID CY-3) and one in Pingtung
(farm ID PT-3). Geographic distribution of the swine
farms and occurrence of ESBL were indicated in Fig. 1.
Overall, the occurrence rate of ESBL-producing E. coli
was 19.7% (54 of 275). Table 2 lists the occurrence of
ESBL-producing E. coli in 16 swine farms.
Table 1 Sequences of primers used for ESBL gene detection
PCR target primer Sequences (5’–3’) Annealing Tm (°C) Predicted PCR size (bp) Reference
blaTEM TEM-F TCGGGGAAATGTGCGCG 55 972 [37]
TEM-R TGCTTAATCAGTGAGGCACC
blaSHV SHV-F GCCTTTATCGGCCCTCACTCAA 54 819 [38]
SHV-R TCCCGCAGATAAATCACCACAATG
blaCTX-M-1-group CTX-M-1-F CCCATGGTTAAAAAATCACTGC 54 942 [39]
CTX-M-1-R CAGCGCTTTTGCCGTCTAAG
blaCTX-M-2-group CTX-M-2-F CGACGCTACCCCTGCTATT 52 552 [40]
CTX-M-2-R CCAGCGTCAGATTTTTCAGG
blaCTX-M-8-group CTX-M-8-F CAAAGAGAGTGCAACGGATG 52 205 [40]
CTX-M-8-R ATTGGAAAGCGTTCATCACC
blaCTX-M-9-group CTX-M-9-F ATGGTGACAAAGAGAGTGCAAC 55 876 [26]
CTX-M-9-R TTACAGCCCTTCGGCGATGATT
blaCTX-M-25-group CTX-M-25-F GCACGATGACATTCGGG 52 327 [40]
CTX-M-25-R AACCCACGATGTGGGTAGC
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Table 3 lists the bla genes and sequence type of ESBL-
producing E. coli. blaCTX-M-1-group and blaCTX-M-9-group
were the two blaCTX-M groups found in ESBL-producing
E. coli. The blaCTX-M-1-group contained blaCTX-M-55 (34 of
54, 63.0%) and blaCTX-M-15 (16 of 54, 29.6%), whereas
blaCTX-M-65 was the only type found from the blaCTX-M-
9 group. All 54 strains contained blaTEM; 27 strains had
blaTEM-1 and the other 27 strains contained blaTEM-116.
One strain found in Pingtung harbored blaTEM-116,
blaCTX-M-55, and blaCTX-M-65. The blaCTX-M-2-group,
blaCTX-M-8-group, blaCTX-M-25-group, and blaSHV types of
ESBL were not detected in this study.
The results of the antibiotic susceptibility testing of
the ESBL-producing E. coli isolated from Chiayi, Tainan,
and Pingtung are shown in Table 4. The susceptibility
testing showed that all 54 ESBL positive isolates were re-
sistant to five antibiotics: ampicillin, cephalothin, ceftio-
fur, tetracycline, and enrofloxacin. Amikacin and
gentamicin were active against 31 strains (57.4%) and 17
strains (31.5%) of ESBL producers, respectively. Overall,
ESBL-producing E. coli exhibited a multi-drug-resistant
phenotype.
Fig. 1 Geographic distribution of the swine farms in Taiwan included in this study. The number of square brackets indicates the number of swine
farms included from each region. The number and occurrence rate of ESBL-producing E. coli are denoted in parentheses
Table 2 Occurrence of ESBL–producing E. coli in 16 farms







Taichung TC-1 6 0 0
Changhua CH-1 15 0 0
Nantou NT-1 11 0 0
Yunlin YL-1 5 0 0
YL-2 6 0 0
Chiayi CY-1 40 19 47.5
CY-2 8 2 25.0
CY-3 29 0 0
CY-4 6 2 33.3
Tainan TN-1 30 6 20.0
Pingtung PT-1 10 2 20.0
PT-2 36 16 44.4
PT-3 37 0 0
PT-4 17 2 11.8
PT-5 11 3 27.3
PT-6 8 2 25.0
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The most frequently seen sequence type of ESBL-
producing E. coli was ST167 (ST10 clonal complex; 7 of
54; 13.0%), followed by ST4981 (6 of 54; 11.1%) and
ST10 (ST10 clonal complex; 5 of 54; 9.3%). There were
four strains of ST617 (ST10 clonal complex, 4/54, 7.4%),
ST457, and ST69 (ST69 clonal complex) and three
strains of ST44 (ST10 clonal complex; 3 of 54; 5.6%) and
ST349 (ST349 clonal complex). ST1638 had two strains
(2 of 54; 3.7%). ST38 (ST38 clonal complex), ST3268,
and ST648 (ST648 clonal complex) had only one strain
each. Nonetheless, we still had 13 strains whose se-
quence types were not matched to any type in the
current databank. Figure 2 indicates the minimal span-
ning tree of the ESBL-producing E. coli STs based on
the degree of allele sharing.
Discussion
The ESBL-producing E. coli were all obtained from the
swine farms located in southern Taiwan. There were five
swine farms in central Taiwan (Taichung, Changhua,
Yunlin, and Nantou) that participated in our study, and
only 43 fecal samples (43 of 275; 15.6%) were collected
from piglets with diarrhea and screened for ESBL. Al-
though the scale of these farms was similar to that of
those located in southern Taiwan, the hygienic proce-
dures or disease control management of individual farms
may contribute to such differences in diarrheal cases.
The specificity of this chromogenic agar was 100% be-
cause all of the pink colonies, indicative of ESBL-
producing E. coli, were phenotypically and genotypically
positive for ESBL. A previous report also suggested the
high sensitivity and specificity of CHROMagar ESBL in
the detection of clinical ESBL-producing Enterobacteria-
ceae [14]. However, our strategy may also lose some
ESBL producers that could grow on blood agar or Mac-
Conkey agar but not on CHROMagar ESBL.
The occurrence of ESBL-producing E. coli in food ani-
mals has been increasing around the world [2]. For ex-
ample, more than 40% of the ESBL-producing E. coli
were detected from piglets with post-weaning diarrhea
in Heilongjiang Province, China [15]. The authors also
compared their findings with those of a similar study in
healthy pigs in China and concluded that ESBL-
producing E. coli were more commonly found in sick
animals [16]. Because we did not investigate the preva-
lence of ESBL in a healthy swine population, there was
no basis of comparison for healthy and diseased swine in
Taiwan. Although diseased pigs are not likely to enter
slaughter or market, fecal shedding from such pigs can
contaminate the piggery environment and provide a res-
ervoir for the exchange of drug-resistance genes [17].
TEM-116–producing E. coli was first identified in Ko-
rean hospitals in a nationwide survey in 2002 [18]. Con-
sequently, a high prevalence of TEM-116 was also
reported in Spain [19]. In animals, TEM-116–producing
E. coli has been detected in dogs [20, 21]. Our results, to
the best of our knowledge, demonstrate for the first time
the presence of blaTEM-116 genes in the ESBL–producing
E. coli from porcine origin. Although most of our TEM-
116–containing strains also had CTX-M, we did find
four E. coli strains that harbored only TEM-116 that ex-
hibited an ESBL phenotype. ESBL producers within the
CTX-M group are becoming more common [22, 23]. In
Europe, CTX-M-1 is broadly disseminated in animals,
whereas CTX-M-14 is most prevalent in animals in
Asian countries [8]. The most frequently found CTX-M
types in our study were CTX-M-15 and CTX-M-55,
whereas CTX-M-14 was reported in healthy and
Table 3 The bla genes and sequence type of ESBL-producing E. coli
Farm location bla gene Sequence Type
Chiayi blaTEM-1 + blaCTX-M-15 (n = 9) 4981 (n = 5), 1638 (n = 1), 3268 (n = 1), NT
a (n = 2)
blaTEM-116 + blaCTX-M-15 (n = 3) 1638 (n = 1), NT (n = 2)
blaTEM-1 + blaCTX-M-55 (n = 5) 167 (n = 4), NT (n = 1)
blaTEM-6 + blaCTX-M-55 (n = 6) 4981 (n = 1), 349 (n = 2), 44 (n = 2), NT (n = 1)
Tainan blaTEM-1 + blaCTX-M-55 (n = 2) NT (n = 2)
blaTEM-116 + blaCTX-M-55 (n = 3) 457 (n = 2), 617 (n = 1)
blaTEM-116 (n = 1) NT (n = 1)
Pingtung blaTEM-1 + blaCTX-M-15 (n = 2) 617 (n = 2)
blaTEM-1 + blaCTX-M-55 (n = 9) 10 (n = 3), 648 (n = 1), 69 (n = 3), 617 (n = 1), NT (n = 1)
blaTEM-116 + blaCTX-M-15 (n = 2) 10 (n = 1), 349 (n = 1)
blaTEM-116 + blaCTX-M-55 (n = 8) NT (n = 1), 10 (n = 1), 457 (n = 2), 617 (n = 1), 167 (n = 1),
69 (n = 1), 38 (n = 1)
blaTEM-116 + blaCTX-M-55 + blaCTX-M-65 (n = 1) NT (n = 1)
blaTEM-116 (n = 3) 44 (n = 1), 167 (n = 1), NT (n = 1)
a: NT new type, there was no comparison standard in the databank
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diseased swine in Korea and China [15, 16, 24]. CTX-M-
55 was first isolated from patients in a hospital in
Thailand; this novel CTX-M type was derived from
CTX-M-15, with only a single substitution of valine in-
stead of alanine at residue 77 [25]. The incidence of
CTX-M-55 has been reported to exceed that of CTX-M-
15 in outpatient infection cases in Chinese county hospi-
tals [26]. Thus, the authors of that study hypothesized
an animal-human transfer of CTX-M-55 because most
of these outpatients in county hospitals live in rural
areas and thus have more chances to come into contact
with infected food animals and farm sewage [26]. In our
study, CTX-M-55 was the predominant ESBL type iso-
lated from swine with diarrhea in southern Taiwan.
CTX-M-55–producing E. coli has also been detected in
the milk of cows with clinical mastitis in the same region
[9]. It is conceivable that ESBL-producing E. coli that
possess CTX-M-55 have spread to the environment.
One strain obtained in Pingtung possessed CTX-M-65
in addition to CTX-M-55 and TEM-116. Although the
detection rate of CTX-M-65 was low compared to those
of CTX-M-55 and CTX-M-15, the presence of CTX-M-
65 has been reported in humans, animals, and vegetables
[15, 24, 27]. These findings underscore the importance
of screening and investigation of the genotypes of
ESBL producers in food animals on a regular basis.
Our investigation did not detect any CTX-M-8 or
CTX-M-25, which were also not detected in previous
studies [15, 28].
Antimicrobial susceptibility test revealed a high fre-
quency of the resistance of ESBL-producing E. coli to
most antimicrobial agents. Inappropriate use or overuse
of antimicrobial agents, including third-generation ceph-
alosporins, may be associated with the emergence of
ESBL-producing E. coli in swine [29]. The selection of
CTX-M-producing E. coli in swine by treatment with
ceftiofur has been documented [30]. It is worthwhile to
consider banning the use of third-generation of
Fig. 2 Minimal spanning tree (MSTree) of ESBL-producing E. coli. Each circle indicates one ST, subdivided into one sector for each isolate, and bordered
by the ST number. White circles or sectors without an ST number denote a lack of comparison standard in the current databank. The numbers on the
connecting line between STs within the MSTree indicate the number of different alleles. Solid lines represent an allele difference of 3 or less, whereas
dotted lines and faint lines indicate an allele difference of 4 or more
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cephalosporins such as ceftiofur in food animals to de-
crease the occurrence of ESBL producers. For example,
the occurrence of ESBL-producing E. coli was reduced
when third-generation cephalosporins were banned in
the Danish pig industry [31]. Forty-two percent of ESBL-
producing E. coli were resistant to amoxicillin/clavulanic
acid. Possible reasons that account for this phenotype
may include hyper production of chromosomal class C
β-lactamase, possession of plasmid-mediated TEM en-
zymes, production of oxacillinases, or production of
inhibitor-resistant TEM by these isolates [32]. In
addition, plasmid mediated AmpC may also cause resist-
ance to amoxicillin/clavulanic acid [8].
The ST10 clonal complexes (ST10, 167, 44, 617) com-
prised most of our ESBL-producing E. coli strains. There
were 13 strains that did not match any ST in the current
database; however, six of these had only a one to three-
allele difference from ST10 clonal complexes. It is fair to
say that ST10 was the dominant clonal complex in our
study. A recent investigation indicated that ESBL-
producing E. coli were commonly isolated from river wa-
ters in southern Taiwan and that ST10 and ST58 was
the most frequently found clonal complexes [33]. The
authors of that study also observed a substantial associ-
ation of these ESBL-producing E. coli with the presence
of chicken farms at that region. Geographically, food
animal farms, including swine, chicken, and cattle, are
primarily situated in southern Taiwan. It is conceivable
that livestock may spread ESBL-producing E. coli from
feces, thus contaminating the environment. We did not
detect ESBL-producing E. coli ST131 (O25:H4) that pos-
sessed CTX-M-15, a leading cause of urinary tract infec-
tions and bacteremia in human medicine globally, in our
study. However, swine and other food animals may play
a role as vectors in the transmission of bacteria to
humans [34], so continued surveillance of food animals
for ESBL-producing E. coli is essential.
Our study has some limitations. Fecal samples from
healthy piglets were not collected and there was no
comparison for the occurrence of ESBL-producing E.
coli between the healthy and diseased populations. The
virulence factors like K88, K99 or 987 P fimbriae genes
in our ESBL-producing E. coli isolates were not screened
and they were not hemolytic when grown on blood agar.
It is possible that the ESBL-producing E. coli in the
present study was not the causative agent for the diar-
rhea of these piglets. We did not detect if these E. coli
isolates produced AmpC-β-lactamases, which also
hydrolyze third-generation cephalosporins. AmpC-
producing E. coli were also found in increasing numbers
in food-producing animals [8]. In addition, profiles of re-
sistant plasmids were not characterized in our study.
Plasmid analysis methods like PCR-based replicon typing
could assign the incompatibility (Inc) groups [35],
whereas replicon sequence typing could discriminate
IncF plasmid variants [36]. Inclusion of plasmid
characterization could have provided insights into the
epidemiology of the ESBL plasmid in our study.
Conclusions
ESBL-producing E. coli from piglets with diarrhea were
isolated from swine farms located in Chiayi, Tainan, and
Pingtung. blaCTX-M-15 and blaCTX-M-55 were the most
commonly detected bla genes. The ST10 clonal com-
plexes comprised most of our ESBL-producing E. coli
strains. Fecal shedding from swine may contaminate the
environment, from a public health perspective, contin-
ued surveillance of ESBL is essential in swine and in
other food animals.
Abbreviations
ATCC: American type culture collection; BLAST: Basic local alignment search
tool; CTX-M: Cefotaximase-Munich; ESBL: Extended-spectrum β-lactamase;
h: hour; MEGA 6.0: Molecular evolutionary genetics analysis software version
6.0; min: minute; MLST: Multilocus sequence typing; NCBI: National center for
biotechnology information; PCR: Polymerase chain reaction; s: second;
SHV: Sulfhydryl variable; ST: Sequence type; TEM: Temoneira
Acknowledgements
The authors would like to thank Hsiuo-Tung Yeh for Fig. 1 graphic drawing
and Dr. Lee-Jene Teng, Department of Clinical Laboratory Sciences and Medical
Biotechnology, National Taiwan University, for providing Klebsiella pneumoniae
ATCC 700603.
Funding
This research was supported by National Taiwan University, No. G049919.
Availability of data and materials
The datasets used and/or analysed during the current study available from
the corresponding author on reasonable request.
Authors’ contributions
W-CL performed all the experiments and was a major contributor in writing
up this manuscript. K-SY coordinated this study and also helped draft this
manuscript. Both authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Ethics approval was not applicable. Animal handling, including fecal sample
collection, was performed or supervised by the approved veterinarians
throughout routine veterinary health management. Consent was obtained
for the samples to be collected at each farm.
Received: 27 September 2016 Accepted: 23 February 2017
References
1. Biehl LG, Hoefling DC. Diagnosis, treatment, and prevention of diarrhea in
7-to 14-day-old pigs. J Am Vet Med Assoc. 1986;188:1144–6.
2. Seiffert SN, Hilty M, Perreten V, Endimiani A. Extended-spectrum
cephalosporin-resistant gram-negative organisms in livestock; an emerging
problem for human health. Drug Resist Updat. 2013;16:22–45.
3. Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human
health. Clin Microbiol Rev. 2011;24:718–33.
4. Bush K, Jacoby GA. Updated functional classification of β-lactamases.
Antimicrob Agents Chemother. 2010;54:969–76.
Lee and Yeh BMC Veterinary Research  (2017) 13:66 Page 8 of 9
5. Gniadkowski M. Evolution of extended-spectrum β-lactamase by mutation.
Clin Microbiol Infect. 2008;14 Suppl 1:11–32.
6. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing
Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis.
2008;8:159–66.
7. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Herman L,
Haesebrouck F, Butaye P. Broad-spectrum β-lactamases among
Enterobacteriaceae of animal origin: molecular aspects, mobility and impact
on public health. FEMS Microbiol Rev. 2010;34:295–316.
8. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. Extended-spectrum β-
lactamase-producing and AmpC-producing Escherichia coli from livestock
and companion animals, and their putative impact on public health: a
global perspective. Clin Microbiol Infect. 2012;18:646–55.
9. Su Y, Yu CY, Tsai Y, Wang SH, Lee C, Chu C. Fluoroquinolone-resistant and
extended-spectrum beta-lactamase-producing Escherichia coli from the milk
of cows with clinical mastitis in Southern Taiwan. J Microbiol Immunol
Infect. 2014. doi: 1016/j.jmii.2014.1010.1003.
10. Shieh HK. The FMD, situiation in Taiwan. J Chin Soc Vet Sci. 1997;23(5):395–402.
11. CLSI. Performance standards for antimicrobial susceptibility testing: twenty-
first informational supplement M100-21. Wayne, PA, USA: CLSI; 2011.
12. Shaheen BW, Oyarzabal OA, Boothe DM. The role of class 1 and 2 integrons
in mediating antimicrobial resistance among canine and feline clinical E. coli
isolates from the US. Vet Microbiol. 2010;144:363–70.
13. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR,
Maiden MCJ, Ochman H, et al. Sex and virulence in Escherichia coli: an
evolutionary perspective. Mol Microbiol. 2006;60:1136–51.
14. Saito R, Koyano S, Nagai R, Okamura N, Moriya K, JKoike K. Evaluation of a
chromogenic agar medium for the detection of extended-spectrum β-
lactamase-producing Enterobacteriaceae. Lett Appl Microbiol. 2010;51:
704–6.
15. Xu G, An W, Wang H, Zhang X. Prevalence and characteristics of extended-
spectrum β-lactamase genes in Escherichia coli isolated from piglets with
post-weaning diarrhea in Heilongjiang province, China. Front Microbiol.
2015;6:1103.
16. Zheng H, Zeng Z, Chen S, Liu Y, Yao Q, Deng Y, Chen X, Lv L, Zhuo C, Chen
Z, et al. Prevalence and characterisation of CTX-M β-lactamases amongst
Escherichia coli isolates from healthy food animals in China. Int J Antimicrob
Agents. 2012;39:305–10.
17. Whitehead TR, Cotta MA. Stored swine manure and swine faeces as
reservoirs of antibiotic resistance genes. Lett Appl Microbiol. 2013;56:264–7.
18. Jeong SH, Bae IK, Lee JH, Sohn SG, Kang GH, Jeon GJ, Kim YH, Jeong BC,
Lee SH. Molecular characterization of extended-spectrum beta-lactamases
produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli
from a korean nationwide survey. J Clin Microbiol. 2004;42:2902–6.
19. Romero EDV, Padilla TP, Hernández AH, Grande RP, Vázquez MF, García IG,
García-Rodríguez JA, Bellido JLM. Prevalence of clinical isolates of Escherichia
coli and Klebsiella spp. producing multiple extended-spectrum β-lactamases.
Diagn Microbiol Infect Dis. 2007;59:433–7.
20. Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich
J, Guerra B, Wieler LH, et al. Emergence of human pandemic O25: H4-ST131
CTX-M-15 extended-spectrum- β-lactamase-producing Escherichia coli
among companion animals. J Antimicrob Chemother. 2010;65:651–60.
21. Rzewuska M, Stefanska I, Kizerwetter-Swida M, Chrobak-Chmiel D,
Szczygielska P, Lesniak M, Binek M. Characterization of extended-spectrum-
β-lactamases produced by Escherichia coli strains isolated from dogs in
Poland. Pol J Microbiol. 2015;64(3):285–8.
22. Zhao WH, Hu ZQ. Epidemiology and genetics of CTX-M extended-spectrum
β-lactamases in Gram-negative bacteria. Crit Rev Microbiol. 2013;39(1):
79–101.
23. Bonnet R. Growing group of extended-spectrum betya-lactamases: the CTX-
M enzymes. Antimicrob Agents Chemother. 2004;48:11–4.
24. Tamang MD, Nam HM, Kim SR, Chae MH, Jang GC, Jung SC, Lim SK.
Prevalence and molecular characterization of CTX-M β-lactamase-producing
Escherichia coli isolated from healthy swine and cattle. Foodborne Pathog
Dis. 2013;10:13–20.
25. Kiratisin P, Apisarnthanarak A, Saifon P, Laesripa C, Kitphati R, Mundy LM.
The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum
beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired
infections in Thailand. Diagn Microbiol Infect Dis. 2007;58:349–55.
26. Zhang J, Zheng B, Zhao L, Wei Z, Ji J, Li L, Xiao Y. Nationwide high
prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli
isolated from patients with community-onset infections in Chinese county
hospitals. BMC Infect Dis. 2014;14:659–69.
27. Riccobono E, Di Pilato V, Di Maggio T, Revollo C, Bartoloni A, Pallecchi L,
Rossolini GM. Characterization of IncI1 sequence type 71 epidemic plasmid
lineage responsible for the recent dissemination of CTX-M-65 extended-
spectrum beta-lactamase in the Bolivian Chaco region. Antimicrob Agents
Chemother. 2007;59:5340–7.
28. Geser N, Stephan R, Hächler H. Occurrence and characteristics of extended-
spectrum β-lactamase (ESBL) producing Enterobacteriaceae in food
producing animals, minced meat and raw milk. BMC Vet Res. 2012;8:21.
29. Barton MD. Impact of antibiotic use in the swine industry. Curr Opin
Microbiol. 2014;19:9–15.
30. Cavaco LM, Abatih E, Aarestrup FM, Guardabassi L. Selection and
persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs
treated with amoxicillin, ceftiofur, or cefquinome. Antimicrob Agents
Chemother. 2008;52:3612–6.
31. Agersø Y, Aarestrup FM. Voluntary ban on cephalosporin use in Danish pig
production has effectively reduced extended-spectrum cephalosporinase-
producing Escherichia coli in slaughter pigs. J Antimicrob Chemother. 2013;
68:569–72.
32. Leflon-Guibout V, Speldooren V, Heym B, Nicolas-Chanoine M-H.
Epidemiological survey of amoxicillin-clavulanate resistance and corresponding
molecular mechanisms in Escherichia coli isolates in France: new genetic
features of blaTEM genes. Antimicrob Agents Chemother. 2000;44:2709–14.
33. Chen PA, Hung CH, Huang PC, Chen JR, Huang IF, Chen WL, Chiou YH,
Hung WY, Wang JL, Cheng MF. Characteristics of CTX-M extended-spectrum
β-lactamase-producing Escherichia coli strains isolated from multiple rivers in
Southern Taiwan. Appl Environ Microbiol. 2016;82(6):1889–97.
34. Dahms C, Hübner N, Kossow A, Mellmann A, Dittmann K, Kramer A.
Occurrence of ESBL-producing Escherichia coli in livestock and farm workers
in Mecklenburg-Western Pomerania, Germany. PLoS One. 2015;10:e0143326.
35. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of
plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219–28.
36. Villa L, García-Fernández A, Fortini D, Carattoli A. Replicon sequence typing
of IncF plasmids carrying virulence and resistance determinants. J
Antimicrob Chemother. 2010;65:2518–29.
37. Stucliffe JG. Nucleotide-sequence of ampicillin resistance gene of Escherichia
coli plasmid pBR322. Proc Natl Acad Sci U S A. 1978;75:3737–41.
38. Chia JH, Chu C, Su LH, Chiu CH, Kuo AJ, Sun CF, Wu TL. Development of a
multiplex PCR and SHV melting-curve mutation detection system for detection
of some SHV and CTX-M-lactamases of Escherichia coli, Klebsiella pneumoniae,
and Enterobacter cloacae in Taiwan. J Clin Microbiol. 2005;43:4486–91.
39. Yu Y, Ji S, Chen Y, Zhou W, Wei Z, Li L, Ma Y. Resistance of strains
producing extended-spectrum β-lactamases and genotype distribution in
China. J Infect. 2007;54:53–7.
40. Woodford N, fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of
genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob
Chemother. 2006;57:154–5.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lee and Yeh BMC Veterinary Research  (2017) 13:66 Page 9 of 9
